Bunsua, Merly L.

HRN: 29-05-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/19/2026
06/26/2026
IV
600mg
Q8H
INFECTED BREAST MASS
Checking Initial Appropriateness 
06/19/2026
MUPIROCIN 2%, 15G (TUBE)
06/19/2026
06/26/2026
IV
2%
BID
Infected Breast Mass
Checking Initial Appropriateness 
06/19/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/19/2026
06/25/2026
IV
500mg
Q8
Infected Breast Mass, Left
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: